Although Africa’s business heavyweights are holding their own in the face of headwinds, their potential remains untapped, ...
“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
It is in Africa’s interests to build resilient and competitive brands, wrote Thebe Ikalafeng, founder and chairman of Brand ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback